Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Escobar syndrome (autosomal recessive multiple pterygium syndrome; MONDO:0009926) is caused by biallelic variants in CHRNG (Gene Symbol), which encodes the fetal γ-subunit of the nicotinic acetylcholine receptor. Affected individuals present with multiple pterygia, congenital joint contractures, facial dysmorphism and variable musculoskeletal anomalies. Inheritance is autosomal recessive, with affected probands homozygous or compound heterozygous for CHRNG variants.
Genetic studies have identified 17 novel probands from five unrelated cohorts: two siblings with homozygous missense CHRNG c.428C>G (p.Pro143Arg) (2 probands) (PMID:25411939), a consanguineous Pakistani family with homozygous CHRNG c.136C>T (p.Arg46Ter) (1 proband) (PMID:30461311), five Tunisian patients including a novel composite heterozygote and two recurrent alleles (5 probands) (PMID:36292632), seven nonlethal MPS cases with long-term follow-up (7 probands) (PMID:30868735), and two unrelated contracture-only cases lacking pterygia (2 probands) (PMID:24254455). Combined with 57 previously published individuals, >64 patients confirm a robust phenotype–genotype correlation (PMID:30868735).
Variant spectrum comprises five truncating alleles (including c.136C>T (p.Arg46Ter), c.117dup (p.Asn40GlnfsTer?), c.459dup (p.Val154fs)), one splice donor site (c.351-1G>A) and six missense substitutions (e.g., c.428C>G (p.Pro143Arg), c.715C>T (p.Arg239Cys), c.794T>G (p.Leu265Arg)). A founder effect is suggested for c.753_754del (p.Asn40GlnfsTer?) observed in Tunisian patients (PMID:36292632).
Segregation analyses in consanguineous pedigrees demonstrate homozygous or compound heterozygous variants in affected individuals with heterozygous parents and unaffected siblings, corroborating autosomal recessive inheritance (PMID:30461311).
Functional assessments reveal acetylcholine receptor deficiency in vitro for truncating variants (p.Arg46Ter) and neuromuscular junction abnormalities on muscle biopsy. Whole-body MRI shows predominant fatty infiltration and muscle bulk reduction, particularly of paravertebral and distal limb muscles, aligning with clinical contractures and scoliosis (PMID:30868735).
Integration of genetic and experimental data supports loss-of-function as the disease mechanism. CHRNG variant testing provides definitive diagnosis, informs genetic counseling and prenatal diagnosis for families at risk.
Gene–Disease AssociationStrong
Genetic EvidenceStrong17 novel probands with 11 unique CHRNG variants (5 truncating, 6 missense) segregating in families Functional EvidenceModerateMuscle biopsy and MRI show neuromuscular junction defects and receptor deficiency consistent with human phenotype |